Our Blogs

• 23Dec2021

  Your Questions Answered - December 2021 Teleconference Q&A

  23Dec2021

  Questions and Answers for the December 2021 Gold Members' Teleconference.

  By Brian Dennehy

  Membership Access | gold

  Q&A

• 20Dec2021

  Gold Members' Teleconference December 2021

  20Dec2021

  2021 Market Recap - Mania Chronicles - Interest Rates - US Focus - 2022 Outlook - Market Update

  By Brian Dennehy

  Membership Access | gold

  Teleconference

• 17Dec2021

  Best and Worst Funds in 2021

  17Dec2021

  Here we look at the 20 Best and Worst funds this year. The wide range of funds emphasises how important fund selection is to your investing success.

  By Brian Dennehy

  Membership Access | free

  Fund analysis

• 17Dec2021

  Best and Worst Sectors in 2021

  17Dec2021

  In this blog, we look at the winning sectors for 2021, as well as those who had a more torrid time.

  By Ben Debney

  Membership Access | gold

  Sector analysis

• 17Dec2021

  Three Dimensions Of Global Performance 2021

  17Dec2021

  This analysis is more interesting this year than in prior years. We look at the performance of global stock markets in three different ways:

  By Ruairi Dennehy

  Membership Access | gold

  Market commentary

• 10Dec2021

  AXA Guest Blog – Gene Editing – the biotech bringing new investment opportunities

  10Dec2021

  The coronavirus pandemic has made biotechnology front page news. The arrival of multiple vaccines in record time has starkly highlighted how innovative – and versatile – the sector can be.

  By Guest Blog

  Membership Access | free

  Guest Blog

• 10Dec2021

  Outrageous Predictions for 2022 – Revolution

  10Dec2021

  Last week Saxo Bank released their “10 Outrageous Predictions for 2022”. These predictions are ‘unlikely’ events which could cause considerable disruption in markets, and are particularly relevant with the unpredictable COVID-19 crisis in mind.

  By Ben Debney

  Membership Access | gold

  Market commentary

• 10Dec2021

  2021 The Year Of Biotech

  10Dec2021

  In the last two years we have all become more appreciative of not just the work of our NHS, but also the extraordinary scientists who typically sit in the background. It is time for us to revisit the biotech funds.

  By Brian Dennehy

  Membership Access | gold

  Sector analysis

• 03Dec2021

  The Cautious Investor Conundrum – Cash Alternatives

  03Dec2021

  Stirring inflation, policy changes, COVID unlock, geo-political tensions… what does all of this mean for a typically cautious investor?

  By Ruairi Dennehy

  Membership Access | gold

  Market commentary

• 03Dec2021

  Global – Dynamic Portfolio Review

  03Dec2021

  This week we review our Dynamic Global Portfolio. We explore how the portfolio is made and its performance, both short term and long term.

  By Ben Debney

  Membership Access | gold

  Dynamic Portfolios

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• >
• >>